Research: Arg-Phe-amide-related peptides may be important regulators of reproductive axis

NewsGuard 100/100 Score

During the last decade, our understanding of this hypothalamus-pituitary-gonadal axis has quickly expanded.

Two novel hypothalamic Arg-Phe-amide-related peptides, kisspeptin and gonadotropin-inhibitory hormone, may be important regulators of the reproductive axis. Kisspeptins are currently recognized as the most potent activators of the hypothalamus-pituitary-gonadal axis. Kisspeptin and its receptor, G protein-coupled receptor 54 (GPR54), are expressed on gonadotropin-releasing hormone neurons, thus regulating the reproductive axis. Kisspeptins strongly release gonadotropin- releasing hormone and luteinizing hormone, even at pre-puberty. Kisspeptin/GPR54 is important for the regulation of sexual maturation and the development of the reproductive system.

Prof. Haluk Kelestimur and colleagues from Medical School, Firat University, Elazig, Turkey used the GT1-7 cell line-expressing gonadotropin-releasing hormone as a model and found that gonadotropin-inhibitory hormone and Arg-Phe-amide-related peptide-1 may have inhibitory effects on kisspeptin-activated gonadotropin-releasing hormone neurons without affecting [Ca2+]i.

These findings which were in the Neural Regeneration Research (Vol. 8, No. 18, 2013) that Arg-Phe-amide-related-peptide-1, in addition to Arg-Phe-amide-related-peptide-3, may be involved in the modulation of the hypothalamus- pituitary-gonadal axis.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis